Rescue therapy in malignant atrophic papulosis: a new era of promising treatments targeting interferon and complement pathways
Targeting both type-I interferon and complement pathways demonstrates significant efficacy in treating malignant atrophic papulosis, offering a potential groundbreaking therapeutic avenue for this rare and life-threatening disease.
Authors
- David Launay (ORCID: https://orcid.org/0000-0003-1840-1817)
- Clément Pruvot (ORCID: https://orcid.org/0000-0003-1894-0749)
- Eric HACHULLA (ORCID: https://orcid.org/0000-0001-7432-847X)
- P. Labalette
- Emmanuel Ledoult (ORCID: https://orcid.org/0000-0002-3925-9541)
- Constance Laroye (ORCID: https://orcid.org/0000-0002-5517-3246)
- D. Staumont‐Sallé (ORCID: https://orcid.org/0000-0002-4780-4212)
- Barbara Noiret (ORCID: https://orcid.org/0000-0003-2063-3836)
- Méryem-Maud Farhat (ORCID: https://orcid.org/0000-0002-9098-4984)
- Lila Ghannem (ORCID: https://orcid.org/0000-0003-3799-8188)
- Alexandre Barbé (ORCID: https://orcid.org/0000-0002-2930-4337)
- Yasmine El Maamar
Institutions
- Inserm (FR)
- Université de Lille (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Lille’s Cardiology Hospital (FR)
- Center for Infection and Immunity of Lille (FR)
- Lille Inflammation Research International Center (FR)
- Universidad Latina (MX)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1093/bjd/ljaf106
- Citations
- 6
- Primary Topic
- Parvovirus B19 Infection Studies
- Type
- article
- Field-Weighted Citation Impact
- 8.38